Research highlights

NAFTNet supports several research projects in the field of fetal medine. Below are studies that are currently active. To obtain more information regarding these research projects, or to contact the principal investigator, you need to register to this site.
NAFTNet endorses these projects, but the conduct of the research is the responsibility of the individual investigators.



Click here to access the list of publications about NAFTNet and scientific publications about research performed under the auspices of NAFTNet.

Oxidative stress in fetuses with decompensated alloimmune hemolytic disease of the fetus and newborn (HDFN).
Hemolytic disease of the fetus and newborn (HDFN) from anti-D and other antibodies still affects 3-4 cases per 1000 births. Free radical damage from oxidative stress may contribute to the anemia of HDFN by damaging formed red blood cells. The proposed study is designed to identify oxidant stresses in fetuses diagnosed with HDFN.

Natural history registry for pregnancies complicated by prenatally diagnosed lower urinary tract obstruction (LUTO) with normal amniotic fluid volume.

Untreated, early midgestation LUTO with oligo/anhydramnios has a very high mortality and renal/pulmonary morbidity in the rare survivor. Prenatal intervention in carefully selected cases has improved survival and reduced pulmonary and renal morbidity. Presently, invasive fetal therapy for LUTO is only justified in the presence of concomitant oligohydramnios. Nothing is documented about the natural history and morbidity or mortality for fetuses with early midgestation LUTO and normal amniotic fluid volumes. A registry of cases with LUTO and normal amniotic fluid could serve as the basis to justify a prospective, randomized trial of shunting versus non-shunting in this population if significant morbidity is found.

Predictive markers in twin-to-twin  transfusion syndrome.
Twin-to-twin transfusion syndrome (TTTS) occurs in 10-15% of all diamniotic-monochorionic (DiMo) pregnancies (identical twins). It is not yet clear why some DiMo pregnancies evolve into TTTS, while others don’t. Furthermore, the evolution of the syndrome is highly variable and unpredictable. In some, the syndrome progresses through increasing stages of severity within days; in others, the severity of the syndrome remains stable for weeks, and may even decrease over time. The aim of the study is to develop tools to stratify patients with severe TTTS into good and poor prognostic groups based on preoperative markers. Two of these markers are corticotropin releasing hormone (CRH) and urocortin (Ucn), known factors associated with placental and fetal stress.

Prenatal cytogenetic diagnosis by array-based copy number analysis.
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis:This multicenter, prospective observational cohort study will compare clinical diagnostic results obtained by conventional cytogenetic microscopy (CC) analysis with those achieved by microarray analysis (MA).  The prenatal diagnostic samples will come from two categories of pregnancies: 1750 patients undergoing prenatal testing for standard indications (Group 1) and another 2250 pregnancies (Group 2) in which testing is performed on account of ultrasound detection of at least one pre-specified fetal structural or growth anomaly, or two or more other unlisted anomalies. The main objective of this multi-center collaborative study is to evaluate the accuracy, efficacy and clinical advantages of prenatal diagnosis using array-based copy number (microarray) analysis as compared with conventional cytogenetic (CC) analysis using microscopy.

Determination of the accuracy of free fetal DNA in maternal plasma in the assessment of the fetal RhD blood type. (STUDY COMPLETED)
Genetic analysis of free fetal DNA in maternal plasma will open the door to major advances in prenatal diagnosis while minimizing potential risks to the pregnancy.  Early efforts have been centered in Europe and the United Kingdom on determination of fetal gender and Rh blood type.  This investigation, sponsored by the Sequenom company, will seek to determine the accuracy of a new assay for fetal gender and RhD typing in the United States.  The combined obstetrical populations of the NAFNet organization will allow the study to be completed in a timely fashion so that the assay can be validated and be available for North American patients.

TTTS pregnancies after laser therapy: Prediction of fetal/neonatal death.
Management options for severe Twin-to-twin Transfusion Syndrome (TTTS) include observation, termination of the pregnancy, amnioreduction, septostomy, endoscopic laser ablation of placental vessels and selective termination of a moribund twin fetus. Informed decisions, as well as directive- and non-directive counseling, imply a reasonable understanding of the natural evolution of the disease and the expected outcome for the various therapeutic interventions. Selective termination, in particular, requires accurate predictive indicators for each fetus, to allow a comparison with other therapies.  If selective termination is chosen, the decision as to which fetus should be targeted for termination should be made based on medical knowledge of the prediction of death. The aim of this study is to analyze predictive factors for fetal or neonatal death for pregnancies with twin-to-twin transfusion syndrome that were treated with endoscopic laser ablation of placental vessels.

Indications for delivery for twin to twin transfusion syndrome after SFLP.
Among live born infants treated for TTTS in utero by selective fetoscopic laser photocoagulation (SFLP) of placental vessels, complications of prematurity remain a major source of morbidity. Studies involving treatment of twin-twin transfusion have significant heterogeneity of gestational age at delivery. It is difficult to determine from the available literature the proportion of spontaneous versus preterm birth following PPROM versus clinically indicated delivery. This information would be of value for counseling families as well as for practitioners determining the timing of delivery. The purpose of this study is to determine the indications for delivery for TTTS after treatment with SFLP.

Natural history of stage I twin-to-twin transfusion syndrome.
Insufficient data exists regarding the behavior of TTTS diagnosed in its earliest stage.  While some cases reverse spontaneously, others progress rapidly.  Currently, there are no known maternal or fetal factors that predict resolution or progression.  Progression to higher stages is associated with worse outcomes.  Better defining the natural course of stage I TTTS could help identify patients who are more likely to progress to higher stages, and how rapidly that progression may occur.  Those patients could be offered definitive treatment such as laser photocoagulation, while those likely to resolve could be managed conservatively.  The goal of this study is to better define, through a multicenter retrospective observational study design, the behavior of Quintero stage I twin-twin transfusion syndrome (TTTS), to address unanswered questions regarding disease management, and to identify demographic, sonographic and echocardiographic predictors of disease behavior.

The efficacy of fetal head biometry, intracranial translucency and other posterior fossa ultrasound measurements in prediction of open spina bifida at 11-14 weeks.
Absence of intracranial translucency (IT) and other fetal posterior fossa ultrasound measurements are efficient first trimester ultrasound markers for diagnosis of fetal open spina bifida (OSB). This study aims to assess the efficacy of IT and ultrasound measurements of the fetal posterior fossa for prediction of fetal OSB and to assess the intra and inter observer variability and visibility in a retrospective patient population.

, North American Fetal Therapy Network. All Rights Reserved.